Investigator Site 102 is a clinical research site located in Minneapolis, Minnesota, United States 55404.
Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.
Investigator Site 102 has participated in 1 clinical trials.
Therapeutic areas: Renal Impairment.
Sponsors: Anthera Pharmaceuticals.
Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Investigator Site 102 has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Investigator Site 102 has 1 clinical trials on record. Their work covers Renal Impairment.
Investigator Site 102 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.